Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.

Jit, M; Brisson, M; Portnoy, A; Hutubessy, R; (2014) Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. The Lancet Global health, 2 (7). e406-14. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(14)70237-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(14)70237-2

Abstract

Share

Download

Filename: Cost-effectiveness of female human_GOLD VoR.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar